Managing chaos – how will entrepreneurs cope with the upcoming crisis?
by multiple authors
Everything biologic and biosimilar in-house counsel need to know about COVID-19
by multiple authors
Video conferencing in patent disputes
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
An exploration of patent pools, R&D and current initiatives.
by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek
2 of 6 Insights
COVID-19 and public compulsory licensing of drugs in Europe
by multiple authors
Marketing authorisation and clinical testing of new drugs
COVID-19: What should brands lawyers be thinking about?
COVID-19: Crackdown by UK's advertising and consumer protection regulators
Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products